A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
Below is a collection of 10 charts that tell the story of market and economic resiliency in 2024 — with all eyes set on 2025. It was a record-setting year on Wall Street, with the S&P 500 ...